SEC Form 4 · accession 0001209191-17-063687
KYNTRA BIO, INC. · KYNB
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jorma Routti
Director
Period of report
Nov 30, 2017
Accepted (ET)
Dec 4, 2017 · 8:23 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000921299
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Nov 30, 2017 | M | 6,000 | $2.90 | A | 133,840 | D | |
| Common StockF1,F2 | Nov 30, 2017 | S | 6,000 | $47.18 | D | 127,840 | D | |
| Common Stock | Dec 1, 2017 | M | 6,000 | $2.90 | A | 133,840 | D | |
| Common StockF1,F3 | Dec 1, 2017 | S | 6,000 | $47.32 | D | 127,840 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F4 | $2.90 | Nov 30, 2017 | M | 6,000 | D | — | Jun 9, 2020 | Common Stock | 6,000 | 6,000 | D |
| Stock Option (Right to Buy)F4 | $2.90 | Dec 1, 2017 | M | 6,000 | D | — | Jun 9, 2020 | Common Stock | 6,000 | 0 | D |
Explanation of responses
- F1Shares sold pursuant to a 10b5-1 plan.
- F2The shares were sold at prices ranging from $46.80 to $47.40. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- F3The shares were sold at prices ranging from $47.00 to $47.70. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price
- F4Fully vested.